Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1954 1
1957 1
1958 1
1959 1
1965 1
1966 1
1968 2
1969 1
1970 3
1971 1
1973 4
1974 3
1975 1
1976 2
1978 3
1979 1
1980 3
1981 4
1982 4
1983 4
1984 3
1985 7
1986 5
1987 12
1988 12
1989 7
1990 9
1991 8
1992 8
1993 6
1994 4
1995 10
1996 5
1997 5
1998 8
1999 11
2000 11
2001 8
2002 11
2003 13
2004 18
2005 15
2006 22
2007 14
2008 17
2009 21
2010 28
2011 34
2012 19
2013 30
2014 26
2015 24
2016 38
2017 43
2018 57
2019 64
2020 69
2021 69
2022 43
Text availability
Article attribute
Article type
Publication date

Search Results

776 results
Results by year
Filters applied: . Clear all
Page 1
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. Among authors: porter b. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.
Deodhar A, Mease PJ, McInnes IB, Baraliakos X, Reich K, Blauvelt A, Leonardi C, Porter B, Das Gupta A, Widmer A, Pricop L, Fox T. Deodhar A, et al. Among authors: porter b. Arthritis Res Ther. 2019 May 2;21(1):111. doi: 10.1186/s13075-019-1882-2. Arthritis Res Ther. 2019. PMID: 31046809 Free PMC article.
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis.
van der Heijde D, Braun J, Deodhar A, Baraliakos X, Landewé R, Richards HB, Porter B, Readie A. van der Heijde D, et al. Among authors: porter b. Rheumatology (Oxford). 2019 Mar 1;58(3):388-400. doi: 10.1093/rheumatology/key128. Rheumatology (Oxford). 2019. PMID: 29860356 Free PMC article. Review.
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study.
Deodhar A, Blanco R, Dokoupilová E, Hall S, Kameda H, Kivitz AJ, Poddubnyy D, van de Sande M, Wiksten AS, Porter BO, Richards HB, Haemmerle S, Braun J. Deodhar A, et al. Among authors: porter bo. Arthritis Rheumatol. 2021 Jan;73(1):110-120. doi: 10.1002/art.41477. Epub 2020 Nov 24. Arthritis Rheumatol. 2021. PMID: 32770640 Free PMC article. Clinical Trial.
Emergency Neuropharmacology.
DeWitt KM, Porter BA. DeWitt KM, et al. Among authors: porter ba. Emerg Med Clin North Am. 2021 Feb;39(1):133-154. doi: 10.1016/j.emc.2020.09.008. Epub 2020 Nov 5. Emerg Med Clin North Am. 2021. PMID: 33218654 Review.
Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
Masnada S, Hedrich UBS, Gardella E, Schubert J, Kaiwar C, Klee EW, Lanpher BC, Gavrilova RH, Synofzik M, Bast T, Gorman K, King MD, Allen NM, Conroy J, Ben Zeev B, Tzadok M, Korff C, Dubois F, Ramsey K, Narayanan V, Serratosa JM, Giraldez BG, Helbig I, Marsh E, O'Brien M, Bergqvist CA, Binelli A, Porter B, Zaeyen E, Horovitz DD, Wolff M, Marjanovic D, Caglayan HS, Arslan M, Pena SDJ, Sisodiya SM, Balestrini S, Syrbe S, Veggiotti P, Lemke JR, Møller RS, Lerche H, Rubboli G. Masnada S, et al. Among authors: porter b. Brain. 2017 Sep 1;140(9):2337-2354. doi: 10.1093/brain/awx184. Brain. 2017. PMID: 29050392 Free article.
Pathology in Practice.
Fratzke AP, Pool RR, Hoppes SM, Porter BF. Fratzke AP, et al. Among authors: porter bf. J Am Vet Med Assoc. 2021 Sep 1;259(5):491-493. doi: 10.2460/javma.259.5.491. J Am Vet Med Assoc. 2021. PMID: 34388016 No abstract available.
776 results